TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JBJ Medicine etc. AB
Closing information (x1000 SEK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover | 0 | 40 | 0 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | -26 | 11 | -17 |
EBITDA | -26 | 11 | -17 |
Total assets | 60 | 95 | 67 |
Current assets | 25 | 60 | 12 |
Current liabilities | 10 | 34 | 17 |
Equity capital | 50 | 61 | 50 |
- share capital | 50 | 50 | 50 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency | 83.3% | 64.2% | 74.6% |
Turnover per employee | 0 | 40 | 0 |
Profit as a percentage of turnover | 27.5% | ||
Return on assets (ROA) | -43.3% | 11.6% | -25.4% |
Current ratio | 250.0% | 176.5% | 70.6% |
Return on equity (ROE) | -52.0% | 18.0% | -34.0% |
Change turnover | -40 | 40 | -19 |
Change turnover % | -100% | -100% | |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.